There were 1,559 press releases posted in the last 24 hours and 413,435 in the last 365 days.

Global Contraceptive Drugs and Devices Market to 2024 - Oral Contraceptives is Estimated to have the Largest Share

Dublin, April 26, 2019 (GLOBE NEWSWIRE) -- The "Contraceptive Drugs and Devices Market- Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering.

The major factors propelling the growth of the contraceptive drugs and devices market include the increasing incidence of the STD, an increasing rate of unintended pregnancies, and the rise in government initiatives.

The number of unwanted pregnancies is increasing globally and it is a matter of serious concern all around the world. According to the centers for disease control and prevention, in 2017, it was estimated that about 194,377 babies were born to women, aged 15-19 years, for a birth rate of 18.8 per 1,000 women, in this age group. Hence, with the increasing rate of unintended pregnancies, there will be a rapid increase in the demand for contraceptive devices, which will ultimately drive the market.

Furthermore, there are countries and their respective governments that have identified the need to curb the growth of unwanted pregnancies and have started a great number of initiatives to educate and prevent the spread of unwanted abortions and pregnancies. The usage of contraceptive pills is one among them. The right to obtain and use contraceptives is part of the fundamental right to privacy guaranteed by the United States Constitution. Thus, government initiatives are also promoting the use of contraceptives to avoid unnecessary births. The health benefits of using the contraceptives have also been significant players in the growth of this market.

In addition, there are a lot of technological advancements in contraceptive drugs, such as the development of emergency oral contraceptive pills that have helped in the growth of the market.

Scope of the Report

As per the scope of the report, contraceptive drugs and devices are the drugs and devices used for birth control. Contraception is more commonly known as fertility and birth control is described as the method used to avoid pregnancy. These devices and drugs function by changing the mechanism of ovulation or by acting as a physical barrier between the sperm and ovum. The proper use of contraceptives, such as female and male condoms also prevents the spread of sexually transmitted diseases.

Key Market Trends

Oral Contraceptives is Estimated to have the Largest Share in the Segmentation by Drugs over the Forecast Period

Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across large regions by global companies and thus easily consumed by a large section of the population, globally. These factors are expected to contribute to the growth of the market over the forecast period. The other forms of contraceptive drugs, such as topical and injectable contraceptives have also witnessed a strong market demand.

North America has been Reported with the Largest Share and Consistent Growth over the Forecast Period.

North America is expected to register a high growth, owing to the presence of sophisticated healthcare infrastructure, the high adoption rate of contraceptive drugs, and the rising number of government initiatives that help in increasing the overall market. A large section of the women population represents the reproductive age in the United States as well as Canada. With that, a significant size of the population is at risk of unintended pregnancy, as their partners do not use a contraceptive method, correctly and consistently. The awareness regarding these products is also high with considerable support being provided by several hospitals to control the patients affected by its misuse. Moreover, the distribution channel of several companies is well established across the United States and Canada, which overall drives the market and contributes to the largest share, over the forecast period.

Competitive Landscape

Over the forecast period, most of the domestic and international players are found focusing on the emerging market and these countries are growing rapidly in the contraceptive drugs and devices market.

Key Topics Covered:

1 INTRODUCTION

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increasing Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 High Cost of Devices and Treatment
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter's Five Forces Analysis

5 MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
5.1.1.1 Oral Contraceptives
5.1.1.2 Topical Contraceptives
5.1.1.3 Contraceptive Injectable
5.1.2 By Device
5.1.2.1 Condoms
5.1.2.2 Diaphragms
5.1.2.3 Cervical Caps
5.1.2.4 Sponges
5.1.2.5 Vaginal Rings
5.1.2.6 IUD
5.1.2.7 Other Devices
5.2 By Gender
5.2.1 Male
5.2.2 Female
5.3 Geography
5.3.1 North America
5.3.1.1 US
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 UK
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East & Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East & Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Pfizer Inc.
6.1.3 Merck & Co. Inc.
6.1.4 Teva Pharmaceuticals Ltd
6.1.5 Agile Therapeutics
6.1.6 Allergan PLC
6.1.7 Ani Pharmaceuticals Inc.
6.1.8 Church & Dwight Co. Inc.
6.1.9 Fuji Latex Co. Ltd
6.1.10 Johnson & Johnson Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/l7hs77

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health

22157.jpg